Success Stories: EB-1A Approved for Research Fellow in Tennessee in the Field of Biochemistry

Client’s Testimonial:

Thank you so much for your help. Your professional and high quality work is critical for my I-140 approval.

On May 12, 2015, We Received another EB1-A (Alien of Extraordinary Ability) Approval for a Research Fellow in the Field of Biochemistry (Approval Notice)

General Field: Biochemistry

Position at the Time of Case Filing: Research Fellow

Country of Origin: China

State of Residence at the Time of Filing: Tennessee

Approval Notice Date: May 12, 2015

Processing Time: 28 Days (13 Days after Premium Processing Requested)

Case Summary:

In this case, the client that we had the opportunity to work with was a research fellow from China in the field of biochemistry. He had conducted his research in the highly specialized area of the proteins involved in the survival and proliferation of cancer cells. His work had resulted in 9 peer-reviewed scientific articles, 1 book chapter, and 2 presentations at national and international conferences; at the time that his case was filed, his publications had been cited at least 155 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work. He had also reviewed 27 manuscripts for at least 9 distinctive, internationally-circulated journals. His superior level of expertise was confirmed in the following quote from a recommender, “[Client] expertly uses fragment-based drug design in my laboratory to discover drugs that target epigenetic proteins […]. Targeted therapy is a newer cancer treatment that involves small molecule drugs that interfere with proteins that play a role in cancer cell growth and survival. Targeted cancer therapies are more efficient and less harmful to normal tissues than traditional chemotherapy drugs, which is why scientists have been so eager in recent years to develop these kinds of therapies. In our study, we first identify target proteins that are instrumental in cancer cell growth and survival in order to design small molecule drugs that target these proteins.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of biochemistry, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 28 days.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.